Cite
Gharzai LA, Pakela J, Jaworski EM, et al. Imaging response assessment for predicting outcomes after bioselection chemotherapy in larynx cancer: A secondary analysis of two prospective trials. Clin Transl Radiat Oncol. 2021;33:30-36doi: 10.1016/j.ctro.2021.12.006.
Gharzai, L. A., Pakela, J., Jaworski, E. M., El Naqa, I., Shah, J., Hawkins, P. G., Spector, M. E., Bradford, C. R., Chinn, S. B., Malloy, K., Kupfer, R., Shuman, A., Morrison, R., Stucken, C. L., Rosko, A., Prince, M. E., Casper, K., Eisbruch, A., Wolf, G., Swiecicki, P. L., Worden, F., & Mierzwa, M. L. (2022). Imaging response assessment for predicting outcomes after bioselection chemotherapy in larynx cancer: A secondary analysis of two prospective trials. Clinical and translational radiation oncology, 3330-36. https://doi.org/10.1016/j.ctro.2021.12.006
Gharzai, Laila A, et al. "Imaging response assessment for predicting outcomes after bioselection chemotherapy in larynx cancer: A secondary analysis of two prospective trials." Clinical and translational radiation oncology vol. 33 (2022): 30-36. doi: https://doi.org/10.1016/j.ctro.2021.12.006
Gharzai LA, Pakela J, Jaworski EM, El Naqa I, Shah J, Hawkins PG, Spector ME, Bradford CR, Chinn SB, Malloy K, Kupfer R, Shuman A, Morrison R, Stucken CL, Rosko A, Prince ME, Casper K, Eisbruch A, Wolf G, Swiecicki PL, Worden F, Mierzwa ML. Imaging response assessment for predicting outcomes after bioselection chemotherapy in larynx cancer: A secondary analysis of two prospective trials. Clin Transl Radiat Oncol. 2021 Dec 23;33:30-36. doi: 10.1016/j.ctro.2021.12.006. eCollection 2022 Mar. PMID: 35024462; PMCID: PMC8728046.
Copy
Download .nbib